The detection of unknown primary tumors in patients with cervical metastases by dual-head positron emission tomography

Oral Oncology

Volumn 35, Issue 4, 1999, Pages 390-394

  Stokkel, M P M ^a   Terhaard, C H ^a   Hordijk, G J ^a   Van Rijk, P P ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

2 (fluorine 18)fluoro deoxy D glucose, FDG; Positron emission tomography, PET; Unknown primary tumor

Indexed keywords

2 FLUORODEOXYGLUCOSE FLUORINE 18; FLUORINE DERIVATIVE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CERVICAL LYMPH NODE; CLINICAL ARTICLE; DIAGNOSTIC VALUE; FEMALE; HEAD AND NECK CANCER; HISTOPATHOLOGY; HUMAN; LYMPH NODE METASTASIS; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; FLUORODEOXYGLUCOSE F18; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; NEOPLASMS, UNKNOWN PRIMARY; RADIOPHARMACEUTICALS; TOMOGRAPHY, EMISSION-COMPUTED; UTERINE CERVICAL NEOPLASMS;

EID: 0033168255     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1368-8375(98)00129-8     Document Type: Article

References (33)

1. MacComb W.S. Diagnosis and treatment of metastatic cervical cancerous nodes from an unknown primary site. American Journal of Surgery. 124:1972;411-449.
2. Million R.R., Cassisi N.J., Mancuso A.A. The unknown primary. In: Million, R.R., Cassisi N.J., editors. Management of Head and Neck Cancer: a Multidisiplinary Approach. 2nd edition. Philadelphia, PA: Lippincott, 1994. p. 311-321.
3. Abbruzzese J.L., Abbruzzese M.C., Hess K.R., Raber M.N., Lenzi R., Frost P. Unknown primary carcinoma: natural history and prognostic factors in 657 consecutive patients. Journal of Clinical Oncology. 12:1994;1272-1280.
4. Wang R.C., Goepfert H., Barber A.E., Wolf P. Unknown primary squamous cell carcinoma metastatic to the neck. Archives of Otolaryngology-Head Neck Surgery. 116:1990;1388-1393.
5. Subramanian R., Chilla R. Halslymphknotenmetastasen bei unbekanntem primartumor. HNO. 43:1995;299-303.
6. McCunnif A.J., Raben M.R. Metastatic carcinoma of the neck from an unknown primary. International Journal of Radiation Oncology, Biology, Physics. 12:1986;1849-1852.
7. Lefebvre J.L., Coche-Dequeant B., Van J.T., Buisset E. Cervical lymph nodes from an unknown primary tumor in 190 patients. American Journal of Surgery. 160:1990;443-446.
8. Strauss L.G., Conti P.S. The appications of PET in clinical oncology. Journal of Nuclear Medicine. 32:1991;623-648.
9. Rigo P., Paulus P., Kaschten B.J., Hustinx R., Bury T., Jerusalem G., Benoit T., Foidart-Willems J. Oncological applications of positron emission tomography with fluorine-18 fluorodeoxyglucose. European Journal of Nuclear Medicine. 23:1996;1641-1674.
10. Hoh C.K., Schiepers C., Seltzer M.A., Gambhir S.S., Silverman D.H. S., Czernin J., Maddahi J., Phelps M.E. PET in oncology: will it replace the other modalities. Seminars in Nuclear Medicine. 27:1997;94-106.
11. Jabour B.A., Choi Y., Hoh C.K., Rege S.D., Soong J.C., Lufkin R.B., Hanafee W.N., Maddahi J., Chaiken L., Bailet J., Phelps M.E., Hawkins R.A., Abemeyor E. Extracranial head and neck: PET imaging with 2-[F18]fluoro-2-deoxy-D-glucose and MR imaging correlation. Radiology. 186:1993;27-35.
12. Minn H., Josensuu H., Ahonen A., Kiemi P. Fluorodeoxyglucose imaging: a method to assess the proliferative activity of human cancer in vivo - comparison with DNA flow cytometry in head and neck tumors. Cancer. 61:1988;1776-1781.
13. Braams J.W., Pruim J., Freling N.J.M., Nikkels P.G.J., Roodenburg J.L.N., Boering G., Vaalburg W., Vermey A. Detection of lymph node metastases of squamous cell cancer of the head and neck with FDG-PET and MRI. Journal of Nuclear Medicine 1995; 36:211-216.
14. Stokkel M.P. M., van Isselt J.W., Hoekstra A., van Rijk P.P. Lesions of 4 mm and 5 mm detected with 18F-FDG using a dual head coincidence camera. European Journal of Nuclear Medicine (Abstract). 25:1998;1032.
15. Jones A.S., Phillips D.E., Helliwel T.R., Roland N.J. Occult metastasis in head and neck squamous carcinoma. European Archives of Otorhinolaryngology. 250:1993;446-449.
16. Clarke R.W., Stell P.M. Squamous carcinoma of head and neck in the young addult. Clinical Otolaryngology. 17:1992;18-23.
17. Leipzig B., Zellmer J.E., Klug D. The role of endoscopy in evaluating patients with head and neck cancer. Archives of Otolaryngology. 111:1985;589-594.
18. McGuirt W.F. Panendoscopy as a screening examination for simultaneous primary tumors in head and neck cancer: a prospective sequential study and review of the literature. Laryngoscope. 92:1982;569-576.
19. Bailet J.W., Abemayor E., Jabour B.A., Hawkins R.A., Hoh C., Ward P.H. Positron emission tomography: a new, precise imaging modality for detection of primary head and neck tumors and assessment of cervical adenopathy. Laryngoscope. 102:1992;281-288.
20. McGuirt W. F., Williams D. W., Keyes J. W., Greven K. M., Watson N. E., Geisinger K. R., Cappellari JO. A comparative diagnostic study of head and neck nodal metastases using positron emission tomography. Laryngoscope 1995;105:373-375.
21. Wahl R.L., Kaminsky M.S., Ethier S.P., Hutchins G.D. The potential of 2-deoxy-2[18F]fluoro-D-glucose (FDG) for the detection of tumor involvement in lymph nodes. Journal of Nuclear Medicine. 31:1990;1831-1835.
22. Benchaou M., Lehman W., Slosman D.O., Becker M., Lemoine R., Rufenacht D., Donath A. The role of FDG-PET in the preoperative assessment of N-staging in head and neck cancer. Acta Otolaryngologica. 116:1996;332-335.
23. Anzai Y., Carroll W.R., Quint D.J., Bradford C.R., Minoshima S., Wolf G.T., Wahl R.L. Recurrence of head and neck cancer after surgery or irradiation: prospective comparison of 2-deoxy-2-[F-18] fluoro-D-glucose PET and MR imaging diagnosis. Radiology. 200:1996;135-141.
24. Lapela M., Grenman R., Kurki T., Joensuu H.J., Leskinen S., Lindholm P., Haaparanta M., Ruotsalainen U., Minn H. Head and neck cancer: detection of recurrence with PET and 2-[F-18] fluoro-2-deoxy-D-glucose. Radiology. 197:1995;205-211.
25. Braams J.W., Pruim J., Kole A.C., Nikkels P.G. J., Vaalburg W., Vermey A. Roodenburg. Detection of unknown primary head and neck tumors by positron emission tomography. International Journal of Oral and Maxillofacial Surgery. 26:1997;112-115.
26. Schipper J.H., Schrader M., Arweiler D., Mueller S., Sciuk J. Die positronenemissions-tomographie zur primartumorsuche bei halslymphknotenmetastasen mit unbekanntem primartumor. HNO. 44:1996;254-257.
27. Kole A.C., Nieweg O.E., Pruim J., Hoekstra H.J., Schraffordt Koops H., Roodenburg J.L. N., Vaalburg W., Vermey A. Detection of unknown occult primary tumors using positron emission tomography. Cancer. 82:1998;1160-1166.
28. Lastoria S., Mainolfi C., Panico R., Alfano B., Vergara E., Acampa W., Varrella P., Caraco C., Salvatore M. Potential role of whole-body PET with F-18 FDG in patients with unknown origin tumors. Journal of Nuclear Medicine 1995;36(Suppl.): 194P (Abstract).
29. van Lingen A., Huijgens P.C., Visser F.C., Ossenkoppele G.J., Hoekstra O.S., Martens H.J.M., Huitink H., Herscheid K.D.M., Green M.V., Teule G.J.J. Performance characteristics of a 511 collimator for imaging positron emitters with a standard gamma-camera. European Journal of Nuclear Medicine 1992;19:315-21.
30. Martin W.H., Delbeke D., Patton J.A., Hendrix B. Weinfeld, Ohana I., Kessler R.M., Sandler M.P. FDG-SPECT: correlation with FDG-PET. Journal of Nuclear Medicine. 36:1995;988-995.
31. Mukherji S.K., Drane W.E., Mancuso A.A., Parsons J.T., Mendenhall W.M., Stringer S. Occult primary tumors of the head and neck: detection with 2-[F-18]fluoro-2-deoxy-D-glucose SPECT. Radiology 1996;199:761-6.
32. Jarritt P.H., Acton P.D. PET imaging using gamma camera systems: a review. Nuclear Medicine Communications. 17:1996;758-766.
33. Stokkel M.P. M., Terhaard C.H., Mertens I.J., Hordijk G.J., van Rijk P.P. Fluorine-18-FDG detection of laryngeal cancer postradiotherapy using dual-head coincidence imaging. Journal of Nuclear Medicine. 39:1998;1385-1387.